Strategic Advisory Board

Home  >>  Cluster Rhine-Neckar  >>  Strategic Advisory Board

The strategic board is an advisory body, endoursed with the task of advising the executive board particularly on strategic issues or reviewing executive board decisions.

Dr. Siegfried Bialojan

Executive Director, Head Life Science Center, Ernst & Young GmbH, Mannheim

Dr. Elmar Bourdon

Manager of Medical Technology Cluster, City of Mannheim

Prof. Dr. Bernd Bukau

Director of Zentrum für Molekulare Biologie Heidelberg (ZMBH)

Dr. Adrian J. Carter

Corporate Vice President of Discovery Research Coordination, Boehringer Ingelheim International GmbH, Ingelheim am Rhein

Dr. Jürgen Gamer

VP Business Development Apogenix AG, Heidelberg

Dr. Jan Gradel

Director Business Development Sino German Hi Tech Park Holding GmbH, Heidelberg

Martin Haag

Site Manager, Roche Diagnostics GmbH, Mannheim

Thomas Hegendoerfer

New Ventures Lead in Germany for Johnson & Johnson Innovation, Neuss

Dr. Wolfgang Niopek

Deputy Executive Director, Chamber of Commerce and Industry Rhine-Neckar, Heidelberg

Dr. Martin Raditsch

CEO INNOVECTIS GmbH, Frankfurt am Main

Dr. Stefan Simianer

Vice President International Development & General Manager R&D, AbbVie Deutschland GmbH & Co. KG, Ludwishafen

Dr. Chistian Tidona

Managing Director BioMed X GmbH, Heidelberg

Prof. Dr. med. Christoph von Kalle

Managing Director, National Center for Tumor Diseases, Heidelberg

Prof. Dr. Heike Andrea Wieland

Director External Ecosystem R&D, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main